GlobalGov › Germany › Pharmaceuticals › Solicitation

Germany – Medical gases – Medizinische Gase

Universitätsklinikum Aachen AöR · Germany government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyUniversitätsklinikum Aachen AöR
CountryGermany
CategoryPharmaceuticals
CPV24111500
PublishedAugust 29, 2025
Procurement stageRequest for Proposal (RFP)
ClosedClosing date not published
StatusClosed — no longer accepting responses
Last verifiedOctober 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Vareniclin (ATC: N07BA03)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Injektionslösung in einer Fertigspritze, ATC L03AX13
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Mepolizumab (ATC-Code: R03DX09).
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum WS Ranibizumab (ATC-Code nach WHO: S01LA04) als Injektionslösung in einer Fertigspritze
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene, ATC V01AA05
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Naloxegol -VV 86
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Calciumcarbonat und Colecalciferol , ATC A12AX01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chinin, ATC M09AA02

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.